Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael H. Silverman, MD
BioStrategics Consulting Ltd
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Glendale, Arizona, United States
- Facility name not stated
Mesa, Arizona, United States
- Facility name not stated
Tucson, Arizona, United States
- Facility name not stated
Jonesboro, Arkansas, United States
- Facility name not stated
Bakersfield, California, United States
- Facility name not stated
Fair Oaks, California, United States
- Facility name not stated
Fresno, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Boynton Beach, Florida, United States
- Facility name not stated
Hialeah, Florida, United States
- Facility name not stated
Miami, Florida, United States
- Facility name not stated
North Miami Beach, Florida, United States
- Facility name not stated
South Miami, Florida, United States
- Facility name not stated
Lexington, Kentucky, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Cambridge, Massachusetts, United States
- Facility name not stated
Missoula, Montana, United States
- Facility name not stated
Las Vegas, Nevada, United States
- Facility name not stated
Emerson, New Jersey, United States
- Facility name not stated
Greenville, North Carolina, United States
- Facility name not stated
Toledo, Ohio, United States
- Facility name not stated
Pittsburgh, Pennsylvania, United States
- Facility name not stated
Aiken, South Carolina, United States
- Facility name not stated
Baytown, Texas, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
McAllen, Texas, United States
- Facility name not stated
McKinney, Texas, United States
- Facility name not stated
San Antonio, Texas, United States
- Facility name not stated
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2014
- Primary completion
- 31 Aug 2016
- Completion
- 31 Aug 2016
- Last update posted
- 14 Jun 2017
- Registered enrollment
- 189
- Registry id
- NCT01590758
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.